Rare diseases
Investigational molecules
Locations
Back to Poland2 clinical trials in Szklarska Poreba, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)PolandPolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advancing treatments for non-small cell lung cancer and small cell lung cancer variations, with particular emphasis on metastatic cases.
These studies aim to evaluate novel therapeutic approaches combining chemotherapy with targeted treatments to improve survival rates in advanced lung cancer patients.
Research centered on comparing the effectiveness of different treatment combinations, including innovative drugs like volrustomig and established therapies such as pembrolizumab.
Current investigations focus on determining optimal therapeutic combinations to enhance progression-free survival and overall patient outcomes.
Studies evaluating preventive approaches in chemotherapy administration, including the assessment of trilaciclib's impact when given prior to standard treatments.
Research aims to optimize treatment sequences and timing to maximize therapeutic benefits while maintaining patient well-being.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
